- Home
- MNMD
MNMD
Mind Medicine (MindMed) Inc.
as 04-18-2025 12:39pm EST
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $25.75 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.70 - $10.44 | Next Earning Date: | 05-07-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Mind Medicine (MindMed) Inc. (MNMD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sullivan Mark | MNMD | Chief Legal Officer | Mar 25 '25 | Sell | $6.74 | 6,576 | $44,322.24 | 316,621 | |
| Barrow Robert | MNMD | Chief Executive Officer | Mar 25 '25 | Sell | $6.74 | 21,208 | $142,941.92 | 856,556 | |
| Karlin Dan | MNMD | Chief Medical Officer | Mar 25 '25 | Sell | $6.74 | 6,836 | $46,074.64 | 446,177 | |
| Liao Carrie | MNMD | Chief Accounting Officer | Mar 25 '25 | Sell | $6.74 | 2,347 | $15,818.78 | 144,923 |
Latest Mind Medicine (MindMed) Inc. News
MNMD Breaking Stock News: Dive into MNMD Ticker-Specific Updates for Smart Investing
Business Wire
4 days ago
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
Business Wire
a month ago
MindMed Announces New Employee Inducement Grants
TipRanks
a month ago
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
TipRanks
a month ago
Psychedelic: atai Life Sciences, NRx report quarterly results
Business Wire
a month ago
MindMed Appoints Matt Wiley as Chief Commercial Officer
TipRanks
a month ago
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
Business Wire
a month ago
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
Business Wire
2 months ago
MindMed to Present at Leerink’s Global Healthcare Conference 2025
Compare MNMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MNMD Mind Medicine (MindMed) Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.